• Nifedipine (BAY-a-1040): From Calcium to Liver

  2026-09-24

  Nifedipine is a defined L-type calcium-channel probe for studying calcium-dependent biology. This article connects its use to recent rat research on PXR-driven liver adaptation while distinguishing established findings from testable experimental questions.

• Ouabain Workflows for Na+/K+-ATPase Research

  2026-09-24

  Use Ouabain to perturb the sodium-potassium pump and test how altered ion gradients shape calcium handling, cellular signaling, and cardiovascular physiology. This guide pairs a practical assay workflow with a careful bridge to new microvascular findings—without treating the reference study as evidence that Ouabain itself improves colitis or vasorelaxation.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-09-23

  Breen and colleagues developed a drug-sensitized yeast growth assay that detected known TOR inhibitors at substantially lower concentrations than a wild-type strain, while distinguishing rapamycin-sensitive and resistant responses. The platform also identified aminophylline as a TOR1-dependent growth inhibitor and found no evidence of TOR inhibition by nebivolol or several other tested compounds, illustrating both its screening potential and the limits of interpreting growth phenotypes as direct target engagement.

• Isradipine (Dynacirc) in Calcium Channel Research

  2026-09-23

  Isradipine (Dynacirc) offers a practical L-type calcium-channel probe for separating vascular smooth muscle relaxation from neuronal calcium signaling. This workflow-focused guide shows how to prepare fresh stocks, design comparative assays, interpret excitotoxicity data, and avoid mistaking L-type inhibition for global calcium-channel blockade.

• QPRT, MLCK, and Breast Cancer Invasion

  2026-09-22

  The reference study identifies quinolinate phosphoribosyltransferase (QPRT) as a metabolic regulator of breast cancer cell motility and connects its activity to myosin light chain phosphorylation. Genetic and pharmacological experiments support a signaling route involving purinergic signaling, PLC, Rho, ROCK, and MLCK, providing a mechanistic rationale for using MLCK inhibition to interrogate tumor-cell invasion.

• A40926: Dalbavancin Precursor and Assay Guide

  2026-09-22

  A40926 is a natural glycopeptide antibiotic and dalbavancin precursor that inhibits bacterial cell wall synthesis by binding D-alanyl-D-alanine termini. Its organism-specific MIC values, mouse septicemia activity, and engineered fermentation data support structured antibiotic-development and Gram-positive bacterial infection research.

• Candida krusei Phases Drive Distinct BMEC Apoptosis

  2026-09-21

  A 2023 study shows that the yeast and hypha phases of Candida krusei both induce apoptosis in bovine mammary epithelial cells, but activate different signaling routes. The phase-specific distinction between mitochondrial and death ligand/receptor mechanisms provides a useful framework for interpreting fungal mastitis pathogenesis and designing pathway-focused experiments.

• 5-Methyl-CTP for Smarter mRNA Assays

  2026-09-21

  Discover how 5-Methyl-CTP can be evaluated as a chemistry-level variable in modified mRNA synthesis, rather than treated as a standalone solution. This guide connects transcript design with the OMV delivery strategy reported for personalized tumor vaccines.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-09-20

  A 2025 GeroScience study developed a genetically drug-sensitized Saccharomyces cerevisiae platform for detecting TOR pathway inhibitors at substantially lower concentrations than conventional yeast assays. The system identified activity from established inhibitors and aminophylline while finding no evidence of TOR inhibition for Nebivolol hydrochloride and several other tested compounds in this model.

• BAPTA: A Causal Tool for Calcium Signaling

  2026-09-19

  BAPTA is a high-affinity calcium chelator that can turn calcium perturbation into a testable causal variable in cell signaling studies. This article explains how to use BAPTA to interpret apoptosis experiments, distinguish pathway involvement from association, and design more defensible calcium-dependent assays.

• Caspase-3/7 Inhibitor I in Apoptosis Mapping

  2026-09-18

  Caspase-3/7 Inhibitor I enables reversible, selective interrogation of executioner caspases in infection and cell-death models. This article shows how to use it as a causal perturbation tool when Candida morphology produces distinct apoptotic signaling outputs.

• Isradipine (Dynacirc): Translating L-Type Insight

  2026-09-18

  A translational framework for using Isradipine (Dynacirc) to dissect L-type calcium signaling across vascular and neuronal models, while avoiding overinterpretation of pharmacological selectivity.

• Verapamil in Hypoxia-Inflammation Assays

  2026-09-17

  Verapamil ((±)-Verapamil) provides a practical pharmacological probe for testing whether prolonged hypoxia engages a ROS-associated TXNIP/NLRP3 inflammatory route in urothelial cells. This guide converts the reference findings into a time-resolved workflow while addressing dosing, solvent, endpoint, and interpretation challenges.

• Drug Repurposing for CRISPR DNA Repair Choice

  2026-09-17

  This Nature Communications study presents a large drug-repurposing screen that maps clinically used compounds to NHEJ, MMEJ, HDR, cell survival, and synthetic-lethal outcomes after CRISPR-induced DNA breaks. Its findings show that pharmacological pathway selection can be combined with genetic perturbation, while ESR2 and AOX1 emerge as mechanistic entry points for improving genome-editing precision and identifying cancer vulnerabilities.

• DiscoveryProbe Protease Inhibitor Library Workflow

  2026-09-16

  Use the DiscoveryProbe Protease Inhibitor Library to move from broad protease activity modulation to mechanism-aware validation in biochemical, cellular, and high-content assays. Its 825-compound format supports parallel testing across apoptosis assay, cancer research, and infectious disease research workflows while preserving a practical path from hit discovery to orthogonal confirmation.

7825 records 1/522 page Next 12345 下5页 Last page